|
Chicken pox vaccination should be introduced for children in the UK
November 12, 2007Severe complications of chicken pox in hospitalized children in the UK and Ireland
The only realistic way of preventing deaths and severe complications arising from chickenpox is to routinely vaccinate children against the disease, concludes research published ahead of print in Archives of Disease in Childhood.
At present, only healthcare workers and others likely to be at risk of contracting or passing on the infection, are routinely immunised in the UK. But vaccination programmes for children have been introduced in several other countries, including the USA, Canada, Australia, and Finland.
The authors base their conclusions on active monitoring by paediatricians in the UK and Ireland of children up to the age of 16 admitted to hospital with severe complications resulting from chickenpox infection.
During the monitoring period, which ran for 13 months between 2002 and 2003, 188 cases were reported to the British Paediatric Surveillance Unit.
Of these, 112 children met the criteria, giving a case rate of 0.82 per 100,000. Their average age was 3 years.
The complications included septic shock, pneumonia, and encephalitis, as well as uncoordinated movement (ataxia), toxic shock syndrome, and "flesh eating" bacterial infection (necrotising fasciitis).
Almost half the children (46%) had additional bacterial infections.
Six children died. One child died in the womb. Although four of the five other children, who were aged between 2 and 14 years, already had a pre-existing medical condition, these were not groups currently targeted for immunisation.
After discharge, 4 out of 10 children had ongoing problems as a result of their infection, including, most commonly, ataxia or skin scarring.
Their average length of hospital stay was seven days, but ranged from one to 68.
Most of these children were healthy before they contracted the virus, say the authors. Universal immunisation could have prevented their complications, as they were mostly old enough to have received the vaccine.
An accompanying editorial in the journal comments: "Chickenpox has traditionally been viewed as an irritating but inevitable infection to be endured during childhood, a rite of passage during the preschool years."
"This benign view persists despite evidence that certain groups, including neonates, adults, pregnant women, and the immunocompromised have higher risks of severe disease," it continues.
The authors point out that new cases of chickenpox have been rising among pre-school children, and for every 1000 cases, between two and five children will have to be admitted to hospital.
The simplest strategy would be to switch from the triple MMR vaccine to one that also included immunity against chickenpox (varicella), using the recently licensed MMRV jab, say the authors. But unfounded fears about MMR are likely make this difficult to implement at present. But varicella vaccine could be offered to all teenagers who have not yet been infected.
"This could prevent cases of severe disease in adults and pregnant women and raise public awareness of the potential and desirability of primary prevention," they conclude.
BMJ-British Medical Journal
The authors base their conclusions on active monitoring by paediatricians in the UK and Ireland of children up to the age of 16 admitted to hospital with severe complications resulting from chickenpox infection.
During the monitoring period, which ran for 13 months between 2002 and 2003, 188 cases were reported to the British Paediatric Surveillance Unit.
Of these, 112 children met the criteria, giving a case rate of 0.82 per 100,000. Their average age was 3 years.
The complications included septic shock, pneumonia, and encephalitis, as well as uncoordinated movement (ataxia), toxic shock syndrome, and "flesh eating" bacterial infection (necrotising fasciitis).
Almost half the children (46%) had additional bacterial infections.
Six children died. One child died in the womb. Although four of the five other children, who were aged between 2 and 14 years, already had a pre-existing medical condition, these were not groups currently targeted for immunisation.
After discharge, 4 out of 10 children had ongoing problems as a result of their infection, including, most commonly, ataxia or skin scarring.
Their average length of hospital stay was seven days, but ranged from one to 68.
Most of these children were healthy before they contracted the virus, say the authors. Universal immunisation could have prevented their complications, as they were mostly old enough to have received the vaccine.
An accompanying editorial in the journal comments: "Chickenpox has traditionally been viewed as an irritating but inevitable infection to be endured during childhood, a rite of passage during the preschool years."
"This benign view persists despite evidence that certain groups, including neonates, adults, pregnant women, and the immunocompromised have higher risks of severe disease," it continues.
The authors point out that new cases of chickenpox have been rising among pre-school children, and for every 1000 cases, between two and five children will have to be admitted to hospital.
The simplest strategy would be to switch from the triple MMR vaccine to one that also included immunity against chickenpox (varicella), using the recently licensed MMRV jab, say the authors. But unfounded fears about MMR are likely make this difficult to implement at present. But varicella vaccine could be offered to all teenagers who have not yet been infected.
"This could prevent cases of severe disease in adults and pregnant women and raise public awareness of the potential and desirability of primary prevention," they conclude.
BMJ-British Medical Journal
Chicken Pox News and Current Chicken Pox Events RSSResearch leading to tools for managing bovine respiratory disease complex
Bovine respiratory disease complex has multiple causes. It's sometimes hard to classify and predict. It also costs the beef industry more than any other disease -- an estimated $690 million in 2006, according to one report.
IAVI statement on new analysis of STEP large-scale AIDS vaccine trial
The International AIDS Vaccine Initiative (IAVI) issued the following statement from its President and CEO, Dr. Seth Berkley, following the release of the first analysis of the entire study population from a late-stage AIDS vaccine trial, known as the STEP study.
New vaccine prevents CMV infection and disease in mice
Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.
MMR, chicken pox vaccines work for preemies
Vaccines for measles-mumps-rubella and varicella, or chicken pox, are effective in extremely preterm infants, even though preemies' immune systems are not as developed as full-term babies. This confirms a long-held assumption by pediatricians and neonatologists across the country.
Biodegradable microspheres deliver time release vaccines, stimulate different immune response
A new vaccine delivery system using microspheres of a biodegradable polymer may not only reduce the need for booster shots in some cases, but also appears to stimulate an immune response that traditional vaccines do not.
Scientists find a key to immune system's ability to remember
Its ability to accurately catalog and recall long past encounters with viruses, bacteria and other pathogens is why we only get the measles or chicken pox once, and is why exposure to deactivated virus particles in vaccines confers protection from disease.
Analysis of Spanish flu cases in 1918-1920 suggests transfusions might help in bird flu pandemic
Transfusions with blood products taken from people who had recovered from Spanish influenza may have reduced risk for death and improved symptoms of hospitalized patients who contracted Spanish influenza complicated by pneumonia. Early treatment was superior to later treatment.
Innovative method for creating a human cytomegalovirus vaccine outlined
Each year, about 40,000 children are born infected with human cytomegalovirus, or CMV, and about 8,000 of these children suffer permanent disabilities due to the virus - almost one an hour.
Research suggests that immune response protects against brain tumor development
In their quest to determine whether immune system surveillance guards against brain tumor development, researchers at The University of Texas M. D. Anderson Cancer Center have found that allergies and asthma that stimulate inflammation may be protective, but use of antihistamines to control the inflammation could eliminate that protection.
Steroids and chicken pox not a good mix
Children who have been treated with steroids and are exposed to chicken pox tend to have a more severe case of the virus.
More Chicken Pox News Articles
 | Caillou Is Sick (Abracadabra series) by Roger Harvey |
 | You Can't Eat Your Chicken Pox, Amber Brown by Paula Danziger |
 | Itchy, Itchy Chicken Pox (Hello Reader!, Level 1) by Grace MacCarone |
 | Arthur's Chicken Pox: An Arthur Adventure (Arthur Adventure Series) by Marc Brown |
 | Goldie Locks Has Chicken Pox by Erin Dealey |
 | Grandpa Spanielson's Chicken Pox Stories: Story #3: The Shrunken Head (I Can Read Book 2) |
 | The Chicken Pox Panic (The Cul-de-Sac Kids #2) by Beverly Lewis |
 | Robots Don't Catch Chicken Pox (The Adventures of the Bailey School Kids, #42) by Debbie Dadey, Marcia T. Jones |
| The chicken pox papers by Susan Terris | |
 | Grandpa Spanielson's Chicken Pox Stories: Story #2: A Snout for Chocolate (I Can Read Book 2) |
| © 2008 BrightSurf.com |